146 results
Page 2 of 8
8-K
EX-10.1
hif5d xycp
11 Mar 21
Cassava Sciences Announces Pharmaceutical Supply Agreement for Simufilam
4:59pm
8-K
EX-10.1
93lqmxf3ubh5f mi
12 Feb 21
Cassava Sciences Announces $200 Million Registered Direct Offering of Common Stock
5:09pm
424B5
in6rxt3yhq5
12 Feb 21
Prospectus supplement for primary offering
12:00am
S-3ASR
2htjjx94pgbqt7 7g6bn
10 Feb 21
Automatic shelf registration
6:04am
S-3ASR
EX-4.5
rqmt2yjr6s1vp
10 Feb 21
Automatic shelf registration
6:04am
S-3ASR
EX-4.6
62wu5g1bet689g
10 Feb 21
Automatic shelf registration
6:04am
8-K
EX-1.1
dyn b55u50076i386f
13 Nov 20
Cassava Sciences Announces Proposed Public Offering of Common Stock
4:36pm
8-K
EX-10.1
381ehruwyl t0eugmi
10 Sep 20
Entry into a Material Definitive Agreement
4:06pm
8-K
EX-99.1
hmwq1 selpa19pf8
6 May 20
Cassava Sciences Reports First Quarter 2020 Financial Results and Provides Business Update
8:16am